Rabeprazole Sodium DR - Award

Contract SPE2D2-26-D-0006 is a bilateral award issued by DLA Troop Support to Golden State Medical Supply, Inc. for the procurement of Rabeprazole Sodium DR 20MG Tablets. The contract is structured as a requirements-type agreement with a base year and four option years, reaching a total estimated value of 6,915,886.73 dollars. The pharmaceuticals are manufactured by Lannett Company, Inc. in Seymour, Indiana, and are supplied in 30, 90, and 500 count bottle configurations. Deliveries are made on an FOB Destination basis to DLA and VA Pharmaceutical Prime Vendors. The agreement incorporates extensive Federal Acquisition Regulation and DFARS clauses, emphasizing supply chain security, contractor ethics, and labor standards. Key compliance requirements include prohibitions on certain telecommunications equipment and software, such as Kaspersky Lab and ByteDance applications, as well as strict adherence to the Contractor Code of Business Ethics and Conduct. Payment is processed through DLA and VA Pharmaceutical Prime Vendors, with electronic invoicing required per DFARS regulations. Performance is measured by the contractor's ability to meet delivery schedules and packaging standards for unit-of-use configurations.